prothena.comProthena Biosciences - expertise in protein dysregulation
prothena.com Profile
prothena.com is a domain
that was created on 2012-10-18,making it 12 years ago.
It has several subdomains, such as ir.prothena.com , among others.
Description：Discover the impact of more than 3 decades of expertise in the biology of misfolded proteins. View our science, pipeline, clinical trial info, and...
Discover prothena.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
prothena.com Information
| HomePage size: 198.206 KB |
| Page Load Time: 0.834166 Seconds |
| Website IP Address: 54.92.229.249 |
prothena.com Similar Website
| Welcome to Biosciences eastern and central Africa - International Livestock Research Institute (BecA |
| Arcus Biosciences - Investors & Media |
| IFF Health & Biosciences: Bioscience for Life |
| Investor Relations | Prothena Corporation plc |
| Bounce protein balls, protein snacks and protein shakes – Bounce Australia |
| Institute for Quantitative and Computational Biosciences – UCLA |
| Protein Powders | Whey Protein Shake and Bar |
| IBB | Institute of Biosciences and Bioengineering | Rice University |
| Sanguine Biosciences |
| ABOUT GENOCEA — Genocea Biosciences |
| TAMHSC Institute of Biosciences & Technology |
| Investors | Avidity Biosciences - Overview |
| Sign In - Kansas City University of Medicine and Biosciences |
| Leadiant Biosciences, |
prothena.com PopUrls
| Prothena Biosciences - expertise in protein dysregulation https://www.prothena.com/ |
| Neurodegenerative & Rare Peripheral Amyloid Disease ... https://www.prothena.com/pipeline/ |
| About Prothena - Learn About Our History, Leadership & ... https://www.prothena.com/about-us/ |
| Prothena Careers - Discover Our Values & View Job ... https://www.prothena.com/careers/ |
| Discover Our Scientific Approach To Misfolded Proteins https://www.prothena.com/our-science/ |
| Clinical Trials & Expanded Access Policy https://www.prothena.com/clinical-trials/ |
| News Center - View Videos, Articles, & Resources https://www.prothena.com/news-center/ |
| Radhika_T https://www.prothena.com/radhika_t/ |
| In Memoriam | Prothena https://www.prothena.com/in-memoriam/ |
| Prothena Presents New Research in the Treatment of Alzheimer's Disease ... https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-Presents-New-Research-in-the-Treatment-of-Alzheimers-Disease-at-Alzheimers |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-to-Highlight-Next-Generation-Treatments-for-Alzheimers-and-Parkinsons-Dise |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2022/Prothena-Announces-FDA-Clearance-of-IND-for-PRX012-a-Subcutaneous-Anti-Amyloid-Beta |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2021/Prothena-and-Novo-Nordisk-Announce-Acquisition-Agreement-for-Prothenas-ATTR-Amyloid |
| Investor Relations | Prothena Corporation plc https://ir.prothena.com/overview/default.aspx |
| Investors | Prothena https://www.prothena.com/investors/ |
prothena.com DNS
| A prothena.com. 3209 IN A 54.92.229.249 |
| MX prothena.com. 3600 IN MX 10 us-smtp-inbound-1.mimecast.com. |
| NS prothena.com. 3600 IN NS dns2.idp365.net. |
| TXT prothena.com. 600 IN TXT sophos-domain-verification=6f79aa0cc576e172620daa66e04f2aa57efedf131af302d3b83a14376feaf065 |
| SOA prothena.com. 3600 IN SOA dns1.idp365.net. hostmaster.idp365.net. 2024032901 7200 3600 1209600 3600 |
prothena.com Httpheader
| Server: nginx |
| Date: Tue, 14 May 2024 03:57:35 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| X-Powered-By: PHP/7.4.33, PleskLin |
| Link: https://www.prothena.com/wp-json/; rel="https://api.w.org/", https://www.prothena.com/wp-json/wp/v2/pages/45; rel="alternate"; type="application/json", https://www.prothena.com/; rel=shortlink |
| Strict-Transport-Security: max-age=16070400 |
| X-Content-Type-Options: nosniff |
| X-UA-Compatible: IE=Edge,chrome=1 |
| X-XSS-Protection: 1; mode=block |
prothena.com Meta Info
| charset="utf-8"/ |
| content="index, follow" name="robots"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="Discover the impact of more than 3 decades of expertise in the biology of misfolded proteins. View our science, pipeline, clinical trial info, and more" name="description" |
| content="max-image-preview:large" name="robots"/ |
| content="All in One SEO (AIOSEO) 4.6.2" name="generator"/ |
| content="en_US" property="og:locale"/ |
| content="Prothena | Heal, Cure and Prevent" property="og:site_name"/ |
| content="article" property="og:type"/ |
| content="Prothena Biosciences - expertise in protein dysregulation" property="og:title"/ |
| content="Discover the impact of more than 3 decades of expertise in the biology of misfolded proteins. View our science, pipeline, clinical trial info, and more" property="og:description"/ |
| content="https://www.prothena.com/" property="og:url"/ |
| content="2019-12-02T17:37:09+00:00" property="article:published_time"/ |
| content="2023-03-02T17:14:25+00:00" property="article:modified_time"/ |
| content="summary" name="twitter:card"/ |
| content="Prothena Biosciences - expertise in protein dysregulation" name="twitter:title"/ |
| content="Discover the impact of more than 3 decades of expertise in the biology of misfolded proteins. View our science, pipeline, clinical trial info, and more" name="twitter:description"/ |
| content="WordPress 6.4.4" name="generator"/ |
prothena.com Ip Information
| Ip Country: United States |
| City Name: Ashburn |
| Latitude: 39.0469 |
| Longitude: -77.4903 |
prothena.com Html To Plain Text
Overview Our History Leadership Board of Directors Quality Policy Partnering Our Science Pipeline Overview AL Amyloidosis Parkinson’s Disease ATTR Amyloidosis Alzheimer’s Disease Publications Clinical Trials Overview Birtamimab Phase 3 Study Prasinezumab Phase 2 Study NNC6019/PRX004 Phase 2 Study PRX005 Phase 1 Study PRX012 Phase 1 Study Expanded Access Policy News Center News Center Featured Articles Press Releases Photos/Videos Fact Sheets Investors Overview Press Releases Events & Presentations Financials & Filings Corporate Governance Stock Information Analyst Coverage Careers Overview Our Values Compensation & Benefits Opportunities Pioneering Neuroscience The need for transformative medicines is greater than ever. At Prothena, we integrate scientific insights around neurological dysfunction and the biology of misfolded proteins to advance a diverse pipeline of novel therapeutics. Our Science TARGETING PROTEIN DYSREGULATION We follow the science. Fueled by a deep scientific expertise built over decades, our research has led to foundational discoveries related to diseases caused by protein dysregulation.REAL IMPACT FOR PATIENTS Now is the time. Significant evidence suggests antibodies that optimally target misfolded proteins can result in clinically meaningful benefit for patients. With a growing pipeline of programs based on this scientific approach, Prothena is advancing therapeutics for neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. Pipeline Learn more about some of Prothena’s ongoing clinical trials: the Phase 3 AFFIRM-AL (birtamimab) trial is now enrolling patients with Mayo Stage IV AL amyloidosis; the Phase 1 ASCENT (PRX012) study is evaluating an investigational therapeutic for patients with Alzheimer’s disease. AFFIRM-AL Study ASCENT Study Follow a manual added link Investors Link to: Careers Careers Link to: Contact Us Contact UsNews Center Careers Contact Us Follow us © 2024 Prothena | Terms of Use | Privacy Policy Scroll to...
prothena.com Whois
Domain Name: PROTHENA.COM Registry Domain ID: 1753140545_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2022-08-02T02:31:25Z Creation Date: 2012-10-18T21:37:11Z Registry Expiry Date: 2027-10-18T21:37:11Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.IDP365.NET Name Server: DNS2.IDP365.NET Name Server: DNS3.IDP365.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:05:52Z <<<